SCHEMBL5588784

SCHEMBL5588784

CCCOc1c(O)c(C(=O)O)c(OCCC)c(OCCC)c1OCCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.35
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GSTA1 P08263 2/20 0.34
GSTP1 P09211 2/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
CREB1 P16220 1/20 0.33
THRA P10827 2/20 0.33
THRB P10828 2/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN11 Q06124 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589703 0.95 KMT2A (0.36) KMT2ATP53LMNAL3MBTL1GSTA1
SCHEMBL5587826 0.95 KMT2A (0.36) KMT2ATP53LMNAL3MBTL1GSTA1
SCHEMBL5588080 0.93 THRA (0.42) TP53L3MBTL1THRATHRBPLA2G2A
SCHEMBL5589001 0.93 THRA (0.42) TP53L3MBTL1THRATHRBPLA2G2A
SCHEMBL5587219 0.92 PLA2G2A (0.44) KMT2ATP53THRATHRBMEN1
SCHEMBL5588097 0.92 PLA2G2A (0.44) KMT2ATP53THRATHRBMEN1
SCHEMBL5589690 0.91 MGAM (0.38) KMT2ATP53L3MBTL1MGAMGAA
SCHEMBL5587736 0.90 PLA2G2A (0.46) KMT2ATP53THRATHRBMEN1
SCHEMBL5587659 0.90 PLA2G2A (0.46) KMT2ATP53THRATHRBMEN1
SCHEMBL5586881 0.90 PLA2G2A (0.46) KMT2ATP53THRATHRBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 KMT2A 1733/4885TP53 3753/4885LMNA 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.